Iconocast Logo

Welcome To Iconocast

How to add a URL link from your web site to the Iconocast web sites

Virtual tour of Southern California

blank

 

Recent News and Articles on the Keywords: nick zagorski + johns hopkins + contact  Related to the article below (Last Update: 5/5/2008)

Pine Plains? Harpp no-hits Arlington
Poughkeepsie Journal, NY - Apr 26, 2008
Brittany Zagorski contributed three hits, and Stephanie Kasson and Lauren Hogan each had two hits for the Presidents (11-0 overall). ...
to venture into community
Greater Milwaukee Today,  USA - Apr 16, 2008
By ED ZAGORSKI - GM Today Staff MEQUON - James Kacmarcik launched a program Monday at Concordia University patterned after Oprah Winfrey?s "Big Give. ...
Source: Google News

Profile of Diane E. Griffin -
N Zagorski - Proceedings of the National Academy of Sciences, 2005 - National Acad Sciences
... Nick Zagorski, Science Writer. ... Currently Professor of Medicine and Neurology at Johns
Hopkins University School of Medicine (Baltimore, MD) and Professor and ...

Profile of Aziz Sancar -
N Zagorski - Proceedings of the National Academy of Sciences, 2005 - National Acad Sciences
... Nick Zagorski, Science Writer. ... is mediated by the enzyme photolyase, which was
identified years earlier by Claud Rupert at Johns Hopkins University (Baltimore ...

Could Micro-RNAs Act Downstream of p53 to Suppress Tumors? -
WS El-Deiry - landesbioscience.com
... Scientists at Johns Hopkins have discovered one way the p53 ... Beer, Anirban Maitra
and Mendell, all of Hopkins. ... 614-2916, wastava@jhmi.edu; Nick Zagorski; 443-287 ...
-

Inaugural Article: Modulation of disease, T cell responses, and measles virus clearance in monkeys … -
CH Pan, A Valsamakis, T Colella, N Nair, RJ Adams, … - Proceedings of the National Academy of Sciences, 2005 - National Acad Sciences
... Harry Feinstone Department of Molecular Microbiology and Immunology, The Johns Hopkins
Bloomberg School of Public Health, Baltimore, MD 21205; Departments of ...

Nicholas Cozzarelli 1938?2006
N Conferences, D Discovery - Nature Structural & Molecular Biology, 2006 - nature.com
... Indeed, in the mid-1980s, Leroy Liu and his associates at Johns Hopkins University
Medical ... Nick will be very much missed ... REFERENCES: Nuzzo, R. & Zagorski, N. Proc ...
-

Progressive Ganglion Cell Degeneration Precedes Neuronal Loss in a Mouse Model of Glaucoma -
BP Buckingham, DM Inman, W Lambert, E Oglesby, DJ … - Journal of Neuroscience, 2008 - Soc Neuroscience
... 2 Michael R. Steele, 3 Monica L. Vetter, 3 Nicholas Marsh-Armstrong ... Utah 84132, 4
Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School ...
-

Inaugural Article: Recent progress in understanding hydrophobic interactions -
EE Meyer, KJ Rosenberg, J Israelachvili - Proceedings of the National Academy of Sciences, 2006 - National Acad Sciences
... All glassware that came into contact with the OTE was cleaned by using Nochromix
reagent (Fisher ... McElroy, WD & Glass, B. (Johns Hopkins Univ Press, Baltimore ...

[CITATION] PAST PRESIDENTS OF THE ACADEMY
SJ ZAGORSKI, GC SHOFFSTALL, BD MARTIN, DS … - Proceedings of the Pennsylvania Academy of Science - Pennsylvania Academy of Science
-

[CITATION] PUBLICATIONS OF INTEREST
A Ergometry, LA Amputation - Arbor

[CITATION] CENTERS/INSTITUTES/AREA PROGRAMS
F AID, U Grads, D OFFERED, A PhD, REB Asia, R … - Directory of Programs in Soviet & East European Studies, 1987 - American Association for the Advancement of Slavic Studies

Source: Google Scholar

Contact: Nick Zagorski
443-287-2251
Johns Hopkins Medical Institutions

New technique to 'see' and protect transplants successful in diabetic animal model

Researchers at Johns Hopkins have found a way to overcome a major stumbling block to developing successful insulin-cell transplants for people with type I diabetes.

Traditional transplant of the cells, accompanied by necessary immune-suppressing drugs, has had highly variable results, from well- to poorly tolerated. Part of the problem, the Hopkins researchers say, is an inability to track the cells—so-called pancreatic beta cells—once they’re inside the body.

Now a new technique encapsulates the insulin-producing cells in magnetic capsules, using an FDA-approved iron compound with an off-label use, which can be tracked by magnetic resonance imaging (MRI). The product, tested in swine and diabetic mice, also simultaneously avoids rejection by the immune system, likely a major reason for transplant failure. The work will be published online next week in Nature Medicine.

“We’re really excited because we can track where we put the cells and make sure their protective housing stays intact and that the cells don’t move. This could solve the mystery of why current transplantation techniques work only for so long,” says one of the study’s authors, Aravind Arepally, M.D., assistant professor of radiology and surgery at Hopkins.

Type I diabetes—the most common childhood sort—causes a person’s immune system to destroy the pancreatic beta cells that make insulin. Without insulin, blood sugar levels can become dangerously high and lead to complications that include blindness or kidney failure. Careful monitoring of blood sugar levels paired with insulin injections can manage the condition, but transplanting healthy beta cells holds more promise for the moment-to-moment fine-tuning of insulin levels, says Arepally.

Current experimental cell transplantation techniques are done “naked and blind,” only lasting a short period of time, according to co-author Jeff Bulte, Ph.D., a professor of radiology and chemical and biomolecular engineering at Hopkins. The unprotected transplanted cells are vulnerable to attack by the recipient’s immune system, and researchers cannot see the cells to figure out why they stop making insulin after a while.

To address both of these challenges, the research team captured beta cells in tiny porous capsules made from a mixture of alginate, a gooey material made from seaweed, and Feridex, a magnetic iron-containing material visible under MRI. They then used a machine that oozes droplets of this mixture to surround and encapsulate individual islet clusters each containing about 500 to 1,000 insulin-producing beta cells. Once the cells are encapsulated, the shell hardens, creating a “magnetocapsule” that measures less than 1/128 of an inch across.

“They’re tiny spheres with nano-scale pores just big enough too let the good stuff out but keep the bad from getting in,” says lead author Brad Barnett, medical student and Howard Hughes fellow at Hopkins. The openings in the magnetocapsule are so small that the body’s immune system sentinels cannot reach and attack the transplanted cells.

The team first transplanted magnetocapsules into the abdomens of mice engineered to develop diabetes. Blood sugar levels in the animals returned to normal within a week and stayed that way for more than two months. In contrast, more than half of untransplanted diabetic mice died, and the rest had very high blood sugar levels.

To mimic human transplantation, the researchers then implanted magnetocapsules into the livers of swine with the help of MRI fluoroscopy, special reflective screens and a computer monitor that provide real-time imaging. The liver was chosen, rather than the usual pancreatic home of beta cells, because it contains many blood vessels that can deliver insulin quickly to the rest of the body.

“Getting the magnetocapsules into the right place requires hand-eye coordination normally required when playing video games,” says Arepally. The team threaded a long needle-like tube into a large vein near the upper thigh and guided the tube upward, across and into a neighboring blood vessel, ending in the body of the liver.

The pigs underwent MRI and blood tests three weeks after magnetocapsule transplantation. MRI showed that the magnetocapsules remained intact in the liver, and blood tests revealed that the cells were still secreting insulin at levels considered functional in people.

“We hope that our magnetocapsules will make tissue-type matching and immunosuppressive drugs problems of the past when it comes to cell-based therapies for type 1 diabetes,” says Bulte.

###

Media Contact: Audrey Huang; 410-614-5105; audrey@jhmi.edu

EMBARGOED FOR RELEASE UNTIL SUNDAY, JULY 29 AT 1:00 p.m. E.T.

The research was funded by the National Institutes of Health and the Howard Hughes Medical Institute.

Authors on the paper are Barnett, Arepally, Parag Karmarkar, Di Qian, Wesley Gilson, Piotr Walczak, Valerie Howland, Leo Lawler, Cal Lauzon, Matthias Stuber, Dara Kraitchman and Bulte, all from Hopkins.

On the Web:
http://www.rad.jhmi.edu/
http://www.nature.com/nm/index.html

 
 
Google
Web www.iconocast.com

Search inside Iconocast for the keyword you have in mind.

Iconocast has collected more than 50,000 articles and press releases on health and science.

These are current and most up to date press releases on the subject you are searching.

We collect current health and science press releases daily from more than 5000 research and health institutes. Here is an example : The elderberry way to perfect skin

We believe if you do search inside Iconocast, you will get better results than searching the web alone.

 
 
Continue News With: News5 ; News6 ; News7 ; News8 ; News9 ; News9A


ADVERTISEMENT

Iconocast is about learning and teaching without borders; we offer eMarketing, Internet Advertising, Internet Marketing, Search Engine Optimization, Search Engine Marketing, Online Branding, and eMarketing News Services.

 

Iconocast Home Page

Contact Iconocast

© 2003-07. ICONOCAST is a trademark of iconocast.com.